Functional pancreatic beta cell mass in rodent and human

Our team works towards a better understanding of pancreatic beta cell development, a basis for the development of new therapies of diabetes.

PI: Raphael SCHARFMANN

Section of human fetal pancreas.

Staining with PDX1 (green) and KI67 (red).

© Adrian Villalba

Pancreatic beta cells are specialized factories devoted to produce large amounts of insulin that is stored within granules and secreted in a tightly regulated fashion. In the pancreas, beta cells are clustered with other endocrine cells (alpha, delta, PP cells), forming microorgans, the islets of Langerhans. Understanding pancreatic endocrine cell development and function is important on a fundamental point of view to better define complex cell types such as insulin-producing beta cells. Such knowledge is also crucial to better understand and treat specific forms of diabetes. Finally, it is now established that beta cell production from multipotent stem cells will require a perfect understanding of the way beta cells form during development. This is also the case for the development of therapeutic approaches based on regenerative medicine.

In the past, we learned a lot on beta cells and their development from rodent models. In rodent, pancreatic development can be studied in great detail. Moreover, islets can be prepared from which beta cells are purified and deeply studied. But we also learned that while rodent and human beta cells share many similarities, they differ on a number of important parameters. In this context, developing ways to analyze human beta cells and their development represents a major challenge.
Recently, our team has:
– Developed the first available functional human beta cell lines
– Used them to model beta cell in physiological and pathological conditions
– Developed innovative ways to study human pancreatic development
– Developed new approaches to study rodent beta, but also alpha and delta cells

Read more

A new article from Cécile Haumaitre and collaborators discusses the origin of pancreatic lesions associated with pancreatic cancer

A new article from Cécile Haumaitre and collaborators discusses the origin of pancreatic lesions associated with pancreatic cancer

Pancreatic ductal adenocarcinoma is currently the fourth leading cause of cancer death worldwide. It is projected to become the second leading cause of cancer death by 2030. Unfortunately, PDAC is often diagnosed at an advanced stage, resulting in a 5-year survival rate of less than 10%. Since the most common precancerous lesions of PDAC are currently not clinically detectable, understanding the mechanisms that lead to their formation and progression is crucial to enabling early diagnosis and more effective therapeutic intervention.

Journée Thématique SFD

Journée Thématique SFD

la Journée Thématique de la SFD aura lieu cette année le 15 décembre 2023 à l’Institut Pasteur de Paris, et sera consacrée au sujet «Diabète, îlots et Insulino-Sécrétion».